Market Exclusive

Analyst Activity – HC Wainwright Reiterates Buy on NASDAQ:SRNE – Sorrento Therapeutics (NASDAQ:SRNE)

Analyst Ratings For NASDAQ:SRNE – Sorrento Therapeutics (NASDAQ:SRNE)

Today, HC Wainwright reiterated its Buy rating on NASDAQ:SRNE – Sorrento Therapeutics (NASDAQ:SRNE) with a price target of $40.00.

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:SRNE – Sorrento Therapeutics (NASDAQ:SRNE)
NASDAQ:SRNE – Sorrento Therapeutics (NASDAQ:SRNE) has insider ownership of 5.00% and institutional ownership of 12.19%.

Recent Trading Activity for NASDAQ:SRNE – Sorrento Therapeutics (NASDAQ:SRNE)
Shares of NASDAQ:SRNE – Sorrento Therapeutics closed the previous trading session at 7.82 up +0.22 2.96% with 416278 shares trading hands.

Exit mobile version